Veterinary Medicines

Injectio Glucosi Isotonica et Natrii Chlorati Isotonica 1:1 WET Baxter (25 g + 4,5 g)/1000 ml Roztwór do infuzji

Authorised
  • Glucose
  • Sodium chloride
Download as PDF

Product identification

Medicine name:
Injectio Glucosi Isotonica et Natrii Chlorati Isotonica 1:1 WET Baxter (25 g + 4,5 g)/1000 ml Roztwór do infuzji
Active substance:
  • Glucose
  • Sodium chloride
Target species:
  • Cattle
  • Goat
  • Cat
  • Dog
  • Pig
  • Horse
  • Sheep
Route of administration:
  • Intraperitoneal use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Glucose
    25.00
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium chloride
    4.50
    gram(s)
    /
    1000.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Cattle
      • Meat and offal
        5
        week
    • Goat
      • Meat and offal
        5
        week
    • Cat
    • Dog
    • Pig
      • Meat and offal
        5
        week
    • Horse
      • Meat and offal
        5
        week
    • Sheep
      • Meat and offal
        5
        week
  • Subcutaneous use
    • Cattle
      • Meat and offal
        5
        week
    • Goat
      • Meat and offal
        5
        week
    • Cat
    • Dog
    • Pig
      • Meat and offal
        5
        week
    • Horse
      • Meat and offal
        5
        week
    • Sheep
      • Meat and offal
        5
        week
  • Intravenous use
    • Cattle
      • Meat and offal
        5
        week
    • Goat
      • Meat and offal
        5
        week
    • Cat
    • Dog
    • Pig
      • Meat and offal
        5
        week
    • Horse
      • Meat and offal
        5
        week
    • Sheep
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Baxter Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bieffe Medital S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0275
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."